Skip to main content
Year archive

Optipharm.CO.,LTD — 2022 filings

All 19 regulatory filings released by Optipharm.CO.,LTD (153710) in 2022, sourced directly from the official regulator.

19 Filings
2022 Period
2022 filings (19)
Filing Released Lang
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-12-28 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2022-12-14 Korean
분기보고서 (2022.09)
Interim / Quarterly Report 9M 2022
2022-11-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-11-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-10-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-10-20 Korean
투자판단관련주요경영사항(민군겸용 기술개발사업(형질전환돼지 기반 수혈가능 이종적혈구제제 기술개발) 국책과제 선정)
Regulatory Filings
2022-09-28 Korean
반기보고서 (2022.06)
Interim / Quarterly Report H1 2022
2022-08-12 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-24 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-16 Korean
사업보고서 (2021.12)
Annual Report FY 2021
2022-03-16 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2021
2022-03-08 Korean
주주총회소집결의
AGM Information
2022-03-08 Korean
주주총회소집공고
AGM Information
2022-03-08 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-01-14 Korean